A promising new heart therapy involving injecting stem cells from persons with severe heart disease back into their diseased hearts is being tested and has shown promising results.

When the stem cells are injected into the damaged hearts,the heart patients have shown marked improvement.

The trial tests, being conducted by Baxter Laboratories and researchers from Northwestern University, is creating quite a stir in the stem cell research and heart disease communities. Preliminary results from their tests were presented to the American Heart Association at their scientific conference in Ft. Lauderdale last fall. 

Dr. Douglas Losordo, a Northwestern University researcher working on the tests, is using technology developed by Baxter to extract and purify stem cells from heart patients with severe angina or who have had prior open-heart surgery or balloon angioplasty procedures to treat their heart disease. The purified stem cells in the test procedures was injected back into the hearts of the patients.

There was a test and a control group totalling 167 patients, most of whom were men,and the test group  showed significant improvement in their conditions. Many have been able to resume moderate physical activity since receiving the treatments. Some of them were home bound and were unable to do normal daily activities like walking up stairs or going out of the house to shop but could do these after they completed the tests.

These trials are the second phase of the three phases required for FDA approval. No date has been announced yet for the start of the third phase.

Adult stem cell treatments such as these are showing similarly encouraging results in other medical areas such as cancer and even spinal injury rehabilitation.  

Other Posts On This Procedure:

 Stem Cell Therapy 

We treat patients with their own stem cells for a variety of diseases and disorders such as diabetes, cerebral palsy, spinal cord injury, heart disease, Parkinson’s, and more. The XCell-Center is the first private institute in the world …  

Healthcare News

Heart failure is a debilitating condition. When heart failure is in an advanced state, the heart is unable to pump enough blood to the body to allow a person to enjoy a normal, productive life. This disease affects over 5 million people … The Company’s pipeline includes multiple product candidates for the treatment of heart damage, including the TGI 1200, an autologous, adipose tissue-derived stem cell treatment for acute heart damage…  

Umbilical Cord Blood Banking: The Potential Benefits

Among the potential applications of stem cell therapy are treatment of heart failure, type-1-dyabetes, brain injuries and neuronal disorders such as cerebral palsy (CP). Some of these uses are already in clinical trials using umbilical-cord … In practice, the World Marrow Donor Association has stated in 2006 that the use of self stem cells to treat childhood leukemia is contra-indicated since the genetic defects that caused the disease are present in the s…  

Stem Cell Ttherapy For Heart Patients

“We’re looking on the time frame here of five years, in the best-case scenario, to have approved cardiac stem cell therapies,” Hare said. Coronary heart disease, which causes heart attacks and angina — chest pain resulting from the … 

Stem Cells Might Reverse Heart Damage From Chemo 

His lab has U.S. Food and Drug Administration approval to treat 30 patients who have heart failure from cardiovascular disease, not chemotherapy. In the trial, participants’ cardiac tissue will be harvested, the stem cells isolated and then expanded in vitro from … Wilate is a von Willebrand Factor/Coagulation Factor VIII Complex (Human) indicated for the treatment of spontaneous and trauma-induced bleeding episodes in patients with severe von Willebrand dise…

HealthNewsReview.org 

The report adds responsible context. The reader ultimately gets a mostly fair-minded report on promising early research into a new kind of stem cell research for heart disease. No reader would expect that the treatment is available or …  

Center for Stem Cell & Regenerative Medicine Receives $8 Million …

The new award will support development of new therapies for heart, cancer and neurological disorders, with funds targeted for early patient clinical trials. This builds on current strengths as cancer and cardiovascular disease are …   

Related Blogs

• Alcohol Nutritional Facts | AliveMax Nutrition
• Lydia climbing stairs | Comedy | Video
• “Taking Care of Aging Knees” by Dennis A Phelps, MD – Colorado Springs Orthopaedic Group from the Spring 2010 issue of SENIOR Magazine | Senior Magazine
• International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human… » StemCell Therapy MD
• International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human… – StemCell Therapy
• International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment Epithelium (RPE) Derived from Human… « StemCell Therapy
• PHOTO: University researcher honored | The Red and Black
• Stem Cell Treatment Update From My Swim Spa
• Poly MVA For Pets » Blog Archive » Research Barks Up a Tree of Long Life
• Stent Graft versus Balloon Angioplasty for Failing Dialysis-Access Grafts | Nephrology Now

Technorati Tags: angioplasty, Baxter Laboratories, cells, damaged, disease, diseased, Dr.Losordo, FDA, heart, hearts, improvement, Northwestern University, open-heart, patients, research, severe, stem, surgery, therapy, trials